CFTR Antibodies

Santa Cruz Biotechnology features a diverse variety of CFTR monoclonal antibodies for studying the cystic fibrosis transmembrane conductance regulator (CFTR) protein. CFTR monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The CFTR protein plays a crucial role in regulating ion transport across epithelial cell membranes, which is essential for maintaining fluid balance in tissues. Mutations in the CFTR gene lead to cystic fibrosis, a serious genetic disorder that affects the lungs and digestive system. Understanding the function and regulation of CFTR is vital for developing targeted therapies for cystic fibrosis and related diseases. CFTR monoclonal antibodies enable researchers to explore protein expression patterns in various cell types and tissues. Advanced research techniques utilizing CFTR monoclonal antibodies help identify potential therapeutic targets and evaluate treatment effectiveness. Investigating CFTR protein interactions and regulatory pathways provides valuable insights into disease mechanisms and progression. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing cystic fibrosis research and therapeutic development.